You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Patent: 8,684,969


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 8,684,969
Title:Injection device with torsion spring and rotatable display
Abstract: The present invention relates to an injection device comprising a torsion spring operatively connected to a dose setting member being adapted to set a dose to be ejected from the injection device. A rotatably mounted display member adapted to display the dose to be ejected in accordance with a setting of the dose setting member is also provided. The rotatably mounted display member is adapted to be rotated over an angle corresponding to at least one revolution of the display member. The display member may be implemented as a dose indicator barrel having numerals arranged along a helical path on an outer surface thereof, or alternatively, as a counting device having two or more display wheels having numerals arranged on an outer surface thereof.
Inventor(s): Moller; Claus Schmidt (Fredensborg, DK), Markussen; Tom Hede (Bagsvaerd, DK), Enggaard; Christian Peter (Vejby, DK)
Assignee: Novo Nordisk A/S (Bagsvaerd, DK)
Application Number:13/626,541
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 8,684,969
Patent Claims:see list of patent claims
Patent landscape, scope, and claims summary:

Analyzing the Claims and Patent Landscape of United States Patent 8,684,969

Introduction

United States Patent 8,684,969, titled "Injection device with torsion spring and rotatable display," is a significant patent in the field of medical devices, particularly injection devices. This analysis will delve into the claims of the patent, its current status, and the broader patent landscape it inhabits.

Patent Overview

Patent Title and Description

The patent 8,684,969 describes an injection device that incorporates a torsion spring and a rotatable display. This device is designed to set and administer precise doses of medication, enhancing user convenience and safety[4].

Patent Claims

The claims of a patent are crucial as they define the scope of the invention and what is protected under the patent. For US 8,684,969, the claims include:

  • The injection device with a torsion spring operatively connected to a dose setting member.
  • The dose setting member adapted to set a dose.
  • The rotatable display that indicates the set dose.
  • Specific mechanisms for dose setting and administration[4].

Current Status and Expiration

Expiration Date

The patent 8,684,969 is set to expire on October 20, 2025. This expiration date is critical for generic or biosimilar manufacturers who may be planning to enter the market with similar devices once the patent protection lapses[1].

Legal Activities

As with many patents, there have been various legal activities surrounding this patent, including filings and updates in patent litigation cases. For instance, this patent is part of an ongoing patent litigation involving Abbreviated New Drug Applications (ANDAs) in the Delaware District Court[1].

Patent Landscape Analysis

Geographical Spread

Patent landscape analysis involves understanding the geographical distribution of similar patents. For injection devices, the geographical spread is global, with major players like Novo Nordisk, Eli Lilly, and Sanofi having significant patent portfolios in the United States, Europe, and other regions[3].

Saturation of the Patent Space

The patent space for injection devices is highly saturated. Numerous patents cover various aspects of injection devices, including dose setting mechanisms, automatic injection devices, and feedback mechanisms. This saturation makes it challenging for new entrants to secure broad claims without infringing existing patents[3].

Key Players and Competitors

Major pharmaceutical and medical device companies are key players in this patent space. Companies like Novo Nordisk, with its extensive portfolio of patents for drugs like Tresiba, and other companies with similar injection device technologies, dominate the landscape. New entrants must navigate this complex web of patents to avoid infringement[5].

Time-Slicing and Trends

Analyzing the patent landscape over time (time-slicing) reveals trends in innovation and patent filing. For instance, there has been a significant increase in patents related to automatic injection devices and smart insulin pens in recent years. This trend indicates a shift towards more sophisticated and user-friendly devices[3].

Niche Areas

Despite the high saturation, there are niche areas within the patent landscape that offer opportunities for innovation. For example, patents focusing on specific mechanisms like dial-down mechanisms for wind-up pens or end-of-dose feedback mechanisms present opportunities for new entrants to carve out a niche[5].

Strategic Insights

Research and Development

A comprehensive patent landscape analysis helps R&D teams identify areas where they can innovate without infringing existing patents. By understanding the saturation level and trends in the patent space, companies can make informed decisions about where to focus their research efforts[3].

Legal and Business Decisions

For attorneys and business leaders, a detailed patent landscape analysis provides strategic insights that can guide critical decisions. This includes assessing the potential rewards and risks of entering a highly saturated patent space and identifying opportunities for licensing or collaboration[3].

Avoiding Infringement

Reading and Understanding Patents

To avoid patent infringement, it is crucial to thoroughly read and understand existing patents. The "claims" section of a patent is particularly important as it details what is covered by the patent. If an aspect is not included in the claims, it is not protected[2].

Seeking Legal Advice

Given the complexity of patent law, seeking advice from a qualified patent lawyer is essential. This is especially true when navigating highly saturated patent spaces to ensure that new inventions do not infringe on existing patents[2].

Conclusion

United States Patent 8,684,969 is a significant patent in the field of injection devices, with its expiration date looming in 2025. Understanding the claims and the broader patent landscape is crucial for companies looking to innovate in this space. Here are some key takeaways:

  • Patent Claims: The patent covers an injection device with a torsion spring and rotatable display, with specific mechanisms for dose setting and administration.
  • Expiration Date: The patent expires on October 20, 2025.
  • Patent Landscape: The space is highly saturated with major players holding extensive patent portfolios.
  • Strategic Insights: A comprehensive patent landscape analysis is essential for R&D and business decisions, helping to identify niche areas and avoid infringement.

Key Takeaways

  • Understand Patent Claims: Thoroughly read and understand the claims of existing patents to avoid infringement.
  • Patent Landscape Analysis: Conduct a comprehensive analysis to identify trends, saturation levels, and niche areas.
  • Seek Legal Advice: Consult with a qualified patent lawyer to navigate complex patent landscapes.
  • Innovation Opportunities: Identify areas where innovation can occur without infringing existing patents.
  • Geographical and Temporal Trends: Analyze the geographical spread and temporal trends in patent filings to make informed decisions.

FAQs

Q1: What is the main invention covered by US Patent 8,684,969? A1: The main invention is an injection device with a torsion spring and a rotatable display for setting and administering precise doses of medication.

Q2: When does US Patent 8,684,969 expire? A2: The patent is set to expire on October 20, 2025.

Q3: How can companies avoid patent infringement in highly saturated spaces? A3: Companies should thoroughly read and understand existing patents, conduct comprehensive patent landscape analyses, and seek advice from qualified patent lawyers.

Q4: What is the significance of time-slicing in patent landscape analysis? A4: Time-slicing helps in understanding trends and changes in patent filings over time, which can guide R&D and business decisions.

Q5: Why is it important to analyze the geographical spread of patents? A5: Analyzing the geographical spread helps in understanding the global distribution of similar patents and identifying potential competitors and collaborators.

Sources

  1. In Re: Ozempic (Semaglutide) Patent Litigation - Justia Dockets.
  2. Team:Sydney Australia/Patent Law - 2017.igem.org.
  3. Patent Landscape Analysis - Uncovering Strategic Insights - AcclaimIP.
  4. US8684969B2 - Injection device with torsion spring and rotatable display - Google Patents.
  5. Tresiba patent expiration - Pharsight.

More… ↓

⤷  Subscribe

Details for Patent 8,684,969

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Novo Nordisk Inc. LEVEMIR insulin detemir Injection 021536 June 16, 2005 8,684,969 2024-10-21
Novo Nordisk Inc. LEVEMIR insulin detemir Injection 021536 October 31, 2013 8,684,969 2024-10-21
Novo Nordisk Inc. RYZODEG 70/30 insulin degludec and insulin aspart Injection 203313 September 25, 2015 8,684,969 2024-10-21
Novo Nordisk Inc. TRESIBA insulin degludec Injection 203314 September 25, 2015 8,684,969 2024-10-21
Novo Nordisk Inc. TRESIBA insulin degludec Injection 203314 November 21, 2018 8,684,969 2024-10-21
Novo Nordisk Inc. FIASP insulin aspart Injection 208751 September 29, 2017 8,684,969 2024-10-21
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

International Patent Family for US Patent 8,684,969

Country Patent Number Estimated Expiration
South Africa 200703706 ⤷  Subscribe
World Intellectual Property Organization (WIPO) 2006045528 ⤷  Subscribe
United States of America 9687611 ⤷  Subscribe
United States of America 8357120 ⤷  Subscribe
United States of America 2022379036 ⤷  Subscribe
United States of America 2020030541 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.